-
-
Call more information
660-596-2224 -
Authors:Hasushita, Yudai MD et al A & A Practice 16(9):p e01616, September 2022. Remimazolam is a recently approved benzodiazepine sedative. We report a case of a 72-year-old man who experienced a cardiac arrest due to severe anaphylaxis immediately after general anesthesia induction. Based on the results of skin tests, including those for dextran 40, an […]
Read MoreAuthors: Nicholas L. McKenzie, B.S.P.H. et al Anesthesiology January 2023, Vol. 138, 42–54. Background Perioperative β-blocker therapy has been associated with increased risk of stroke. However, the association between β-blocker initiation before the day of surgery and the risk of stroke is unknown. The authors hypothesized there would be no association between preoperative β-blocker initiation within […]
Read MoreAuthor: Paul Pomerantz, FACHE ASA Monitor January 2023, Vol. 87, 12. Happy New Year! As I write this, it is mid-November, and I am always amazed at how quickly the end of year comes upon us. At ASA, it is a busy time: annual meeting reconciliation and follow-up, membership renewals, performance reviews, end-of-year accounting, implementation of […]
Read MoreAuthors: Heather Lander, MD; et al ASA Monitor January 2023, Vol. 87, 20–21. According to a recent World Health Organization (WHO) publication, in 2020 the number of people aged 60 years and older outnumbered children younger than 5 years worldwide (asamonitor.pub/3NC2L83). Simultaneous to the rapidly growing older population, their surgical and perioperative needs are also increasing. […]
Read MoreAuthor: Mariah Taylor Becker’s Hospital Review A recent study found risk-adjusted survival rates for cardiac arrest can vary as much as 71 percent between two randomly chosen hospitals. The study, published Dec. 15 in JACC Cardiovascular Interventions, analyzed 4,787 patients from 231 hospitals. The median survival rate was 36 percent, but the rates varied from 20 percent to […]
Read More